Unlocking the Potential of Digital Biomarkers to Overcome Biological Variability of Mood & Behaviour & Drive More Reliable Patient Selection
Time: 11:00 am
day: Track 2 AM Day 1
Details:
- Emphasizing the clinical value of objective and continuous measurements with wearable sensors
- Challenges and pitfalls in developing minimal burden portable biomarker assessment tools
- Selecting the right digital measures to identify and enrich patient population and generate Phase 1 through Phase 3 data
- Capturing trait and/or state digital markers: the value of longitudinal assessments from Phase 1 to Phase 3 in drug development
